首页 > 最新文献

Inflammation Research最新文献

英文 中文
Systemic immune inflammation index with all-cause and cause-specific mortality: a meta-analysis. 全身免疫炎症指数与全因和特定原因死亡率的关系:一项荟萃分析。
IF 4.8 3区 医学 Q2 CELL BIOLOGY Pub Date : 2024-10-14 DOI: 10.1007/s00011-024-01959-5
Wei Li, Xiaoning Wang, Houze Diao, Yuting Yang, Liyi Ding, Wenru Huan, Yaozhi Chen, Weiwei Cui

Importance: Studies have reported an association among systemic immune inflammation index (SII), all-cause and cause-specific mortality, but the results are inconsistent.

Objective: To comprehensively explore the association between Systemic Immune Inflammation (SII) and the risk of all-cause mortality, cardiovascular disease (CVD), and cancer mortality.

Evidence review: A meta-analysis was conducted by reviewing existing literature. The search encompassed prominent databases including PubMed, Embase, Cochrane, and the Web of Science, with the cutoff date set at March 1, 2024. Furthermore, subgroup analyses and dose-response assessments were undertaken to provide a nuanced exploration of mortality risk factors.

Findings: A total of 33 articles were included (427,819 participants). In the study, SII was associated with an increased risk of all-cause mortality (HR = 1.45, 95%CI [1.36,1.54], P < 0.05). SII increased the risk of CVD mortality (HR = 1.44, 95%CI [1.29,1.60], P < 0.05). The Linear independence shows that for every 100 units increase in SII, the risk of all-cause and CVD death increases by 5% and 6%. SII was not associated with a statistically significant risk of cancer death (HR = 1.09, 95%CI [0.96,1.23], P < 0.05).

Conclusions and relevance: Meta-analysis showed that SII was associated with all-cause mortality and CVD mortality. More data and basic research are needed to confirm the association.

重要性:有研究报告称,全身免疫炎症指数(SII)与全因和特定病因死亡率之间存在关联,但结果并不一致:全面探讨全身免疫炎症(SII)与全因死亡率、心血管疾病(CVD)和癌症死亡率风险之间的关联:证据回顾:通过回顾现有文献进行了一项荟萃分析。检索范围包括PubMed、Embase、Cochrane和Web of Science等著名数据库,截止日期为2024年3月1日。此外,还进行了亚组分析和剂量反应评估,以深入探讨死亡风险因素:共纳入 33 篇文章(427 819 名参与者)。在研究中,SII 与全因死亡风险增加有关(HR = 1.45,95%CI [1.36,1.54],P 结论和相关性:Meta 分析表明,SII 与全因死亡率和心血管疾病死亡率相关。需要更多的数据和基础研究来证实这种关联。
{"title":"Systemic immune inflammation index with all-cause and cause-specific mortality: a meta-analysis.","authors":"Wei Li, Xiaoning Wang, Houze Diao, Yuting Yang, Liyi Ding, Wenru Huan, Yaozhi Chen, Weiwei Cui","doi":"10.1007/s00011-024-01959-5","DOIUrl":"https://doi.org/10.1007/s00011-024-01959-5","url":null,"abstract":"<p><strong>Importance: </strong>Studies have reported an association among systemic immune inflammation index (SII), all-cause and cause-specific mortality, but the results are inconsistent.</p><p><strong>Objective: </strong>To comprehensively explore the association between Systemic Immune Inflammation (SII) and the risk of all-cause mortality, cardiovascular disease (CVD), and cancer mortality.</p><p><strong>Evidence review: </strong>A meta-analysis was conducted by reviewing existing literature. The search encompassed prominent databases including PubMed, Embase, Cochrane, and the Web of Science, with the cutoff date set at March 1, 2024. Furthermore, subgroup analyses and dose-response assessments were undertaken to provide a nuanced exploration of mortality risk factors.</p><p><strong>Findings: </strong>A total of 33 articles were included (427,819 participants). In the study, SII was associated with an increased risk of all-cause mortality (HR = 1.45, 95%CI [1.36,1.54], P < 0.05). SII increased the risk of CVD mortality (HR = 1.44, 95%CI [1.29,1.60], P < 0.05). The Linear independence shows that for every 100 units increase in SII, the risk of all-cause and CVD death increases by 5% and 6%. SII was not associated with a statistically significant risk of cancer death (HR = 1.09, 95%CI [0.96,1.23], P < 0.05).</p><p><strong>Conclusions and relevance: </strong>Meta-analysis showed that SII was associated with all-cause mortality and CVD mortality. More data and basic research are needed to confirm the association.</p>","PeriodicalId":13550,"journal":{"name":"Inflammation Research","volume":null,"pages":null},"PeriodicalIF":4.8,"publicationDate":"2024-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142464298","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Single-cell transcriptome analysis of the mouse lungs during the injury and recovery periods after lipopolysaccharide administration. 单细胞转录组分析小鼠肺部在服用脂多糖后的损伤期和恢复期的情况。
IF 4.8 3区 医学 Q2 CELL BIOLOGY Pub Date : 2024-10-08 DOI: 10.1007/s00011-024-01951-z
Hou-Ping Wang, Jian He, Jian-Rong He, Dan-Dan Li, He Huang, Bing Chen

Objective: This study sought to investigate the cellular and molecular alterations during the injury and recovery periods of ALI and develop effective treatments for ALI.

Methods: Pulmonary histology at 1, 3, 6, and 9 days after lipopolysaccharide administration mice were assessed. An unbiased single-cell RNA sequencing was performed in alveoli tissues from injury (day 3) and recovery (day 6) mice after lipopolysaccharide administration. The roles of Fpr2 and Dpp4 in ALI were assessed.

Results: The most severe lung injury occurred on day 3, followed by recovery entirely on day 9 after lipopolysaccharide administration. The numbers of Il1a+ neutrophils, monocytes/macrophages, and Cd4+ and Cd8+ T cells significantly increased at day 3 after LPS administration; subsequently, the number of Il1a+ neutrophils greatly decreased, the numbers of monocytes/macrophages and Cd4+ and Cd8+ T cells continuously increased, and the number of resident alveolar macrophages significantly increased at day 6. The interactions between monocytes/macrophages and pneumocytes during the injury period were enhanced by the Cxcl10/Dpp4 pair, and inhibiting Dpp4 improved ALI significantly, while inhibiting Fpr2 did not.

Conclusions: Our results offer valuable insights into the cellular and molecular mechanisms underlying its progression and identify Dpp4 as an effective therapeutic target for ALI.

研究目的本研究旨在调查 ALI 损伤和恢复期的细胞和分子变化,并开发 ALI 的有效治疗方法:方法:评估给小鼠注射脂多糖后 1、3、6 和 9 天的肺组织学。方法:对给小鼠注射脂多糖后 1、3、6 和 9 天的肺组织学进行评估;对给小鼠注射脂多糖后损伤期(第 3 天)和恢复期(第 6 天)的肺泡组织进行无偏见的单细胞 RNA 测序。评估了Fpr2和Dpp4在ALI中的作用:结果:最严重的肺损伤发生在给予脂多糖后的第3天,随后在第9天完全恢复。给予 LPS 后第 3 天,Il1a+ 中性粒细胞、单核细胞/巨噬细胞、Cd4+ 和 Cd8+ T 细胞的数量显著增加;随后,Il1a+ 中性粒细胞的数量大幅减少,单核细胞/巨噬细胞、Cd4+ 和 Cd8+ T 细胞的数量持续增加,肺泡巨噬细胞的数量在第 6 天显著增加。Cxcl10/Dpp4对损伤期间单核细胞/巨噬细胞和肺细胞之间的相互作用有增强作用,抑制Dpp4可明显改善ALI,而抑制Fpr2则不会:我们的研究结果为了解ALI进展的细胞和分子机制提供了有价值的见解,并确定了Dpp4作为ALI的有效治疗靶点。
{"title":"Single-cell transcriptome analysis of the mouse lungs during the injury and recovery periods after lipopolysaccharide administration.","authors":"Hou-Ping Wang, Jian He, Jian-Rong He, Dan-Dan Li, He Huang, Bing Chen","doi":"10.1007/s00011-024-01951-z","DOIUrl":"https://doi.org/10.1007/s00011-024-01951-z","url":null,"abstract":"<p><strong>Objective: </strong>This study sought to investigate the cellular and molecular alterations during the injury and recovery periods of ALI and develop effective treatments for ALI.</p><p><strong>Methods: </strong>Pulmonary histology at 1, 3, 6, and 9 days after lipopolysaccharide administration mice were assessed. An unbiased single-cell RNA sequencing was performed in alveoli tissues from injury (day 3) and recovery (day 6) mice after lipopolysaccharide administration. The roles of Fpr2 and Dpp4 in ALI were assessed.</p><p><strong>Results: </strong>The most severe lung injury occurred on day 3, followed by recovery entirely on day 9 after lipopolysaccharide administration. The numbers of Il1a<sup>+</sup> neutrophils, monocytes/macrophages, and Cd4<sup>+</sup> and Cd8<sup>+</sup> T cells significantly increased at day 3 after LPS administration; subsequently, the number of Il1a<sup>+</sup> neutrophils greatly decreased, the numbers of monocytes/macrophages and Cd4<sup>+</sup> and Cd8<sup>+</sup> T cells continuously increased, and the number of resident alveolar macrophages significantly increased at day 6. The interactions between monocytes/macrophages and pneumocytes during the injury period were enhanced by the Cxcl10/Dpp4 pair, and inhibiting Dpp4 improved ALI significantly, while inhibiting Fpr2 did not.</p><p><strong>Conclusions: </strong>Our results offer valuable insights into the cellular and molecular mechanisms underlying its progression and identify Dpp4 as an effective therapeutic target for ALI.</p>","PeriodicalId":13550,"journal":{"name":"Inflammation Research","volume":null,"pages":null},"PeriodicalIF":4.8,"publicationDate":"2024-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142390244","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Molecular mechanism of mechanical pressure induced changes in the microenvironment of intervertebral disc degeneration. 机械压力诱导椎间盘退变微环境变化的分子机制。
IF 4.8 3区 医学 Q2 CELL BIOLOGY Pub Date : 2024-10-08 DOI: 10.1007/s00011-024-01954-w
Fei Liu, Song Chao, Lei Yang, Chaoqi Chen, Wutao Huang, Feng Chen, Zhiwei Xu

Background: Lower back pain, as a typical clinical symptom of spinal degenerative diseases, is emerging as a major social problem. According to recent researches, the primary cause of this problem is intervertebral disc degeneration (IVDD). IVDD is closely associated with factors such as age, genetics, mechanical stimulation (MS), and inadequate nutrition. In recent years, an increasing number of studies have further elucidated the relationship between MS and IVDD. However, the exact molecular mechanisms by which MS induces IVDD remain unclear, highlighting the need for in-depth exploration and study of the relationship between MS and IVDD.

Methods: Search for relevant literature on IVDD and MS published from January 1, 2010, to the present in the PubMed database.

Results: One of the main causes of IVDD is MS, and loading modalities have an impact on the creation of matrix metalloproteinase, the metabolism of the cellular matrix, and other biochemical processes in the intervertebral disc. Nucleus pulposus cell death induced by MS, cartilage end-plate destruction accompanied by pyroptosis, apoptosis, iron death, senescence, autophagy, oxidative stress, inflammatory response, and ECM degradation interact with one another to form a cooperative signaling network.

Conclusion: This review discusses the molecular mechanisms of the changes in the microenvironment of intervertebral discs caused by mechanical pressure, explores the interaction between mechanical pressure and IVDD, and provides new insights and approaches for the clinical prevention and treatment of IVDD.

背景:下背痛作为脊柱退行性疾病的典型临床症状,正在成为一个主要的社会问题。根据最新研究,造成这一问题的主要原因是椎间盘退变(IVDD)。IVDD 与年龄、遗传、机械刺激(MS)和营养不足等因素密切相关。近年来,越来越多的研究进一步阐明了 MS 与 IVDD 之间的关系。然而,MS诱导IVDD的确切分子机制仍不清楚,这凸显了深入探索和研究MS与IVDD之间关系的必要性:方法:在PubMed数据库中检索2010年1月1日至今发表的有关IVDD和多发性硬化症的相关文献:IVDD的主要病因之一是多发性硬化症,加载方式会影响基质金属蛋白酶的生成、细胞基质的新陈代谢以及椎间盘内的其他生化过程。MS诱导的髓核细胞死亡、软骨终板破坏伴随的热凋亡、细胞凋亡、铁死亡、衰老、自噬、氧化应激、炎症反应和ECM降解相互作用,形成一个合作的信号网络:本综述讨论了机械压力导致椎间盘微环境变化的分子机制,探讨了机械压力与 IVDD 之间的相互作用,为 IVDD 的临床预防和治疗提供了新的见解和方法。
{"title":"Molecular mechanism of mechanical pressure induced changes in the microenvironment of intervertebral disc degeneration.","authors":"Fei Liu, Song Chao, Lei Yang, Chaoqi Chen, Wutao Huang, Feng Chen, Zhiwei Xu","doi":"10.1007/s00011-024-01954-w","DOIUrl":"https://doi.org/10.1007/s00011-024-01954-w","url":null,"abstract":"<p><strong>Background: </strong>Lower back pain, as a typical clinical symptom of spinal degenerative diseases, is emerging as a major social problem. According to recent researches, the primary cause of this problem is intervertebral disc degeneration (IVDD). IVDD is closely associated with factors such as age, genetics, mechanical stimulation (MS), and inadequate nutrition. In recent years, an increasing number of studies have further elucidated the relationship between MS and IVDD. However, the exact molecular mechanisms by which MS induces IVDD remain unclear, highlighting the need for in-depth exploration and study of the relationship between MS and IVDD.</p><p><strong>Methods: </strong>Search for relevant literature on IVDD and MS published from January 1, 2010, to the present in the PubMed database.</p><p><strong>Results: </strong>One of the main causes of IVDD is MS, and loading modalities have an impact on the creation of matrix metalloproteinase, the metabolism of the cellular matrix, and other biochemical processes in the intervertebral disc. Nucleus pulposus cell death induced by MS, cartilage end-plate destruction accompanied by pyroptosis, apoptosis, iron death, senescence, autophagy, oxidative stress, inflammatory response, and ECM degradation interact with one another to form a cooperative signaling network.</p><p><strong>Conclusion: </strong>This review discusses the molecular mechanisms of the changes in the microenvironment of intervertebral discs caused by mechanical pressure, explores the interaction between mechanical pressure and IVDD, and provides new insights and approaches for the clinical prevention and treatment of IVDD.</p>","PeriodicalId":13550,"journal":{"name":"Inflammation Research","volume":null,"pages":null},"PeriodicalIF":4.8,"publicationDate":"2024-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142390243","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
5-oxoETE promote thrombosis in antiphospholipid syndrome by triggering NETs formation through PLC/PKC/ERK pathway. 5-oxoETE 通过 PLC/PKC/ERK 途径触发 NETs 的形成,从而促进抗磷脂综合征的血栓形成。
IF 4.8 3区 医学 Q2 CELL BIOLOGY Pub Date : 2024-10-08 DOI: 10.1007/s00011-024-01956-8
Xiaodong Song, Xufeng Chen, Dong Wang, Jie Bai

Background: One mechanism by which antiphospholipid syndrome (APS) IgG contribute to thrombotic events in patients with APS is through the potentiation of neutrophil extracellular traps (NETs) release. However, the exact mechanism by which APS IgG induces NETs formation and thrombosis has not been fully elucidated.

Methods: We conducted untargeted metabolomics on serum samples from thrombotic APS patients to identify metabolic changes. The effect of 5-oxoETE on NETs formation and oxidative stress was evaluated in vitro by treating neutrophils with various concentrations of 5-oxoETE. The involvement of the PLC/PKC/ERK signaling pathway in 5-oxoETE-induced NETs formation was examined using pharmacological inhibitors. In vivo, we assessed the effects of inhibiting 5-oxoETE synthesis or blocking its receptor (OXE-R) on NETs formation and thrombosis in APS mouse models.

Results: Serum metabolomics revealed significantly elevated levels of 5-oxoETE in APS patients. In vitro experiments demonstrated that 5-oxoETE, via OXE-R activation of the PLC/PKC/ERK signaling pathway, increased NETs formation and oxidative stress in a dose-dependent manner. In vivo, inhibiting 5-oxoETE synthesis or OXE-R reduced NETs formation and attenuated venous thrombosis in APS mice models.

Conclusion: This study identifies 5-oxoETE as a critical mediator of NET formation and thrombosis in APS. Targeting 5-oxoETE or OXE-R may offer a promising therapeutic approach for thrombotic APS and other NET-associated autoimmune diseases.

背景:抗磷脂综合征(APS)IgG导致APS患者血栓事件的机制之一是通过促进中性粒细胞胞外捕获物(NETs)的释放。然而,APS IgG诱导NETs形成和血栓形成的确切机制尚未完全阐明:我们对血栓性 APS 患者的血清样本进行了非靶向代谢组学研究,以确定代谢变化。通过用不同浓度的 5-oxoETE 处理中性粒细胞,在体外评估了 5-oxoETE 对 NETs 形成和氧化应激的影响。使用药理抑制剂检测了 PLC/PKC/ERK 信号通路在 5-oxoETE 诱导的 NETs 形成中的参与情况。在体内,我们评估了抑制 5-oxoETE 合成或阻断其受体(OXE-R)对 APS 小鼠模型中 NETs 形成和血栓形成的影响:结果:血清代谢组学显示,APS 患者的 5-oxoETE 水平明显升高。体外实验表明,5-oxoETE 通过 OXE-R 激活 PLC/PKC/ERK 信号通路,以剂量依赖的方式增加了 NETs 的形成和氧化应激。在体内,抑制 5-oxoETE 合成或 OXE-R 可减少 APS 小鼠模型中 NETs 的形成并减轻静脉血栓形成:本研究发现 5-oxoETE 是 APS 中 NET 形成和血栓形成的关键介质。针对5-oxoETE或OXE-R可能为血栓性APS和其他NET相关自身免疫性疾病提供一种有前景的治疗方法。
{"title":"5-oxoETE promote thrombosis in antiphospholipid syndrome by triggering NETs formation through PLC/PKC/ERK pathway.","authors":"Xiaodong Song, Xufeng Chen, Dong Wang, Jie Bai","doi":"10.1007/s00011-024-01956-8","DOIUrl":"https://doi.org/10.1007/s00011-024-01956-8","url":null,"abstract":"<p><strong>Background: </strong>One mechanism by which antiphospholipid syndrome (APS) IgG contribute to thrombotic events in patients with APS is through the potentiation of neutrophil extracellular traps (NETs) release. However, the exact mechanism by which APS IgG induces NETs formation and thrombosis has not been fully elucidated.</p><p><strong>Methods: </strong>We conducted untargeted metabolomics on serum samples from thrombotic APS patients to identify metabolic changes. The effect of 5-oxoETE on NETs formation and oxidative stress was evaluated in vitro by treating neutrophils with various concentrations of 5-oxoETE. The involvement of the PLC/PKC/ERK signaling pathway in 5-oxoETE-induced NETs formation was examined using pharmacological inhibitors. In vivo, we assessed the effects of inhibiting 5-oxoETE synthesis or blocking its receptor (OXE-R) on NETs formation and thrombosis in APS mouse models.</p><p><strong>Results: </strong>Serum metabolomics revealed significantly elevated levels of 5-oxoETE in APS patients. In vitro experiments demonstrated that 5-oxoETE, via OXE-R activation of the PLC/PKC/ERK signaling pathway, increased NETs formation and oxidative stress in a dose-dependent manner. In vivo, inhibiting 5-oxoETE synthesis or OXE-R reduced NETs formation and attenuated venous thrombosis in APS mice models.</p><p><strong>Conclusion: </strong>This study identifies 5-oxoETE as a critical mediator of NET formation and thrombosis in APS. Targeting 5-oxoETE or OXE-R may offer a promising therapeutic approach for thrombotic APS and other NET-associated autoimmune diseases.</p>","PeriodicalId":13550,"journal":{"name":"Inflammation Research","volume":null,"pages":null},"PeriodicalIF":4.8,"publicationDate":"2024-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142390242","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Inhibition of neuroinflammation and neuronal damage by the selective non-steroidal ERβ agonist AC-186. 选择性非甾体 ERβ 激动剂 AC-186 抑制神经炎症和神经元损伤
IF 4.8 3区 医学 Q2 CELL BIOLOGY Pub Date : 2024-10-03 DOI: 10.1007/s00011-024-01952-y
Folashade O Katola, Misturah Y Adana, Olumayokun A Olajide

Background: AC-186 (4-[4-4-Difluoro-1-(2-fluorophenyl) cyclohexyl] phenol) is a neuroprotective non-steroidal selective oestrogen receptor modulator. This study investigated whether inhibition of neuroinflammation contributed to neuroprotective activity of this compound.

Methods: BV-2 microglia were treated with AC-186 (0.65-5 μM) prior to stimulation with LPS (100 ng/mL). Levels of pro-inflammatory mediators and proteins were then evaluated.

Results: Treatment of LPS-activated BV-2 microglia with AC-186 resulted in significant (p < 0.05) reduction in TNFα, IL-6, NO, PGE2, iNOS and COX-2. Further investigations showed that AC-186 decreased LPS-induced elevated levels of phospho-p65, phospho-IκBα and acetyl-p65 proteins, while blocking DNA binding and luciferase activity of NF-κB. AC-186 induced significant (p < 0.05) increase in protein expression of ERβ, while enhancing ERE luciferase activity in BV-2 cells. Effects of the compound on oestrogen signalling in the microglia was confirmed in knockdown experiments which revealed a loss of anti-inflammatory activity following transfection with ERβ siRNA. In vitro neuroprotective activity of AC-186 was demonstrated by inhibition of activated microglia-mediated damage to HT-22 neurons.

Conclusions: This study established that AC-186 produces NF-κB-mediated anti-inflammatory activity, which is proposed as a contributory mechanism involved in its neuroprotective actions. It is suggested that the anti-inflammatory activity of this compound is linked to its agonist effect on ERβ.

背景:AC-186(4-[4-4-二氟-1-(2-氟苯基)环己基]苯酚)是一种具有神经保护作用的非甾体选择性雌激素受体调节剂。本研究探讨了抑制神经炎症是否有助于该化合物的神经保护活性:方法:在LPS(100 ng/mL)刺激前,用AC-186(0.65-5 μM)处理BV-2小胶质细胞。然后评估促炎介质和蛋白质的水平:结果:用 AC-186 处理 LPS 激活的 BV-2 小胶质细胞可显著降低 iNOS 和 COX-2 的水平(p 2)。进一步研究表明,AC-186 降低了 LPS 诱导的磷酸-p65、磷酸-IκBα 和乙酰-p65 蛋白水平的升高,同时阻断了 NF-κB 的 DNA 结合和荧光素酶活性。AC-186对NF-κB有明显的诱导作用:本研究证实,AC-186 可产生 NF-κB 介导的抗炎活性,这被认为是其神经保护作用的一个促成机制。有人认为,该化合物的抗炎活性与其对 ERβ 的激动作用有关。
{"title":"Inhibition of neuroinflammation and neuronal damage by the selective non-steroidal ERβ agonist AC-186.","authors":"Folashade O Katola, Misturah Y Adana, Olumayokun A Olajide","doi":"10.1007/s00011-024-01952-y","DOIUrl":"https://doi.org/10.1007/s00011-024-01952-y","url":null,"abstract":"<p><strong>Background: </strong>AC-186 (4-[4-4-Difluoro-1-(2-fluorophenyl) cyclohexyl] phenol) is a neuroprotective non-steroidal selective oestrogen receptor modulator. This study investigated whether inhibition of neuroinflammation contributed to neuroprotective activity of this compound.</p><p><strong>Methods: </strong>BV-2 microglia were treated with AC-186 (0.65-5 μM) prior to stimulation with LPS (100 ng/mL). Levels of pro-inflammatory mediators and proteins were then evaluated.</p><p><strong>Results: </strong>Treatment of LPS-activated BV-2 microglia with AC-186 resulted in significant (p < 0.05) reduction in TNFα, IL-6, NO, PGE<sub>2</sub>, iNOS and COX-2. Further investigations showed that AC-186 decreased LPS-induced elevated levels of phospho-p65, phospho-IκBα and acetyl-p65 proteins, while blocking DNA binding and luciferase activity of NF-κB. AC-186 induced significant (p < 0.05) increase in protein expression of ERβ, while enhancing ERE luciferase activity in BV-2 cells. Effects of the compound on oestrogen signalling in the microglia was confirmed in knockdown experiments which revealed a loss of anti-inflammatory activity following transfection with ERβ siRNA. In vitro neuroprotective activity of AC-186 was demonstrated by inhibition of activated microglia-mediated damage to HT-22 neurons.</p><p><strong>Conclusions: </strong>This study established that AC-186 produces NF-κB-mediated anti-inflammatory activity, which is proposed as a contributory mechanism involved in its neuroprotective actions. It is suggested that the anti-inflammatory activity of this compound is linked to its agonist effect on ERβ.</p>","PeriodicalId":13550,"journal":{"name":"Inflammation Research","volume":null,"pages":null},"PeriodicalIF":4.8,"publicationDate":"2024-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142365141","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The role of Pim-1 kinases in inflammatory signaling pathways. Pim-1 激酶在炎症信号通路中的作用。
IF 4.8 3区 医学 Q2 CELL BIOLOGY Pub Date : 2024-10-01 Epub Date: 2024-07-30 DOI: 10.1007/s00011-024-01924-2
Hye Suk Baek, Nacksung Kim, Jong Wook Park, Taeg Kyu Kwon, Shin Kim

Objective and design: This observational study investigated the regulatory mechanism of Pim-1 in inflammatory signaling pathways.

Materials: THP-1, RAW 264.7, BV2, and Jurkat human T cell lines were used.

Treatment: None.

Methods: Lipopolysaccharide (LPS) was used to induce inflammation, followed by PIM1 knockdown. Western blot, immunoprecipitation, immunofluorescence, and RT-PCR assays were used to assess the effect of PIM1 knockdown on LPS-induced inflammation.

Results: PIM1 knockdown in macrophage-like THP-1 cells suppressed LPS-induced upregulation of pro-inflammatory cytokines, inducible nitric oxide synthase, cyclooxygenase-2, phosphorylated Janus kinase, signal transducer and activator of transcription 3, extracellular signal-regulated kinase, c-Jun N-terminal kinase, p38, and nuclear factor kappa B p65 (NF-κB p65). It also suppressed upregulation of inhibitor of NF-κB kinase α/β and enhanced the nuclear translocation of NF-κB p65. Moreover, it inhibited the upregulation of Nod-like receptor family pyrin domain-containing 3 (NLRP3) and cleavage of caspase-1 induced by co-treatment of LPS with adenosine triphosphate. Additionally, p-transforming growth factor-β-activated kinase 1 (TAK1) interacted with Pim-1. All three members of Pim kinases (Pim-1, Pim-2, and Pim-3) were required for LPS-mediated inflammation in macrophages; however, unlike Pim-1 and Pim-3, Pim-2 functioned as a negative regulator of T cell activity.

Conclusions: Pim-1 interacts with TAK1 in LPS-induced inflammatory responses and is involved in MAPK/NF-κB/NLRP3 signaling pathways. Additionally, considering the negative regulatory role of Pim-2 in T cells, further in-depth studies on their respective functions are needed.

目的和设计:本观察性研究探讨了 Pim-1 在炎症信号通路中的调控机制:使用THP-1、RAW 264.7、BV2和Jurkat人T细胞系:处理:无:方法:使用脂多糖(LPS)诱导炎症,然后敲除 PIM1。用 Western 印迹、免疫沉淀、免疫荧光和 RT-PCR 检测评估 PIM1 基因敲除对 LPS 诱导炎症的影响:结果:在巨噬细胞样 THP-1 细胞中敲除 PIM1 抑制了 LPS 诱导的促炎细胞因子、诱导型一氧化氮合酶、环氧化酶-2、磷酸化 Janus 激酶、信号转导和激活转录 3、细胞外信号调节激酶、c-Jun N 端激酶、p38 和核因子卡巴 B p65(NF-κB p65)的上调。它还抑制了 NF-κB 激酶抑制因子 α/β 的上调,并增强了 NF-κB p65 的核转位。此外,它还能抑制 LPS 与三磷酸腺苷联合处理所诱导的 Nod 样受体家族含 pyrin 域 3(NLRP3)的上调和 caspase-1 的裂解。此外,p-转化生长因子-β-活化激酶 1(TAK1)与 Pim-1 相互作用。Pim激酶的所有三个成员(Pim-1、Pim-2和Pim-3)都是LPS介导的巨噬细胞炎症所必需的;然而,与Pim-1和Pim-3不同,Pim-2是T细胞活性的负调控因子:结论:在 LPS 诱导的炎症反应中,Pim-1 与 TAK1 相互作用,并参与 MAPK/NF-κB/NLRP3 信号通路。此外,考虑到 Pim-2 在 T 细胞中的负调控作用,还需要进一步深入研究它们各自的功能。
{"title":"The role of Pim-1 kinases in inflammatory signaling pathways.","authors":"Hye Suk Baek, Nacksung Kim, Jong Wook Park, Taeg Kyu Kwon, Shin Kim","doi":"10.1007/s00011-024-01924-2","DOIUrl":"10.1007/s00011-024-01924-2","url":null,"abstract":"<p><strong>Objective and design: </strong>This observational study investigated the regulatory mechanism of Pim-1 in inflammatory signaling pathways.</p><p><strong>Materials: </strong>THP-1, RAW 264.7, BV2, and Jurkat human T cell lines were used.</p><p><strong>Treatment: </strong>None.</p><p><strong>Methods: </strong>Lipopolysaccharide (LPS) was used to induce inflammation, followed by PIM1 knockdown. Western blot, immunoprecipitation, immunofluorescence, and RT-PCR assays were used to assess the effect of PIM1 knockdown on LPS-induced inflammation.</p><p><strong>Results: </strong>PIM1 knockdown in macrophage-like THP-1 cells suppressed LPS-induced upregulation of pro-inflammatory cytokines, inducible nitric oxide synthase, cyclooxygenase-2, phosphorylated Janus kinase, signal transducer and activator of transcription 3, extracellular signal-regulated kinase, c-Jun N-terminal kinase, p38, and nuclear factor kappa B p65 (NF-κB p65). It also suppressed upregulation of inhibitor of NF-κB kinase α/β and enhanced the nuclear translocation of NF-κB p65. Moreover, it inhibited the upregulation of Nod-like receptor family pyrin domain-containing 3 (NLRP3) and cleavage of caspase-1 induced by co-treatment of LPS with adenosine triphosphate. Additionally, p-transforming growth factor-β-activated kinase 1 (TAK1) interacted with Pim-1. All three members of Pim kinases (Pim-1, Pim-2, and Pim-3) were required for LPS-mediated inflammation in macrophages; however, unlike Pim-1 and Pim-3, Pim-2 functioned as a negative regulator of T cell activity.</p><p><strong>Conclusions: </strong>Pim-1 interacts with TAK1 in LPS-induced inflammatory responses and is involved in MAPK/NF-κB/NLRP3 signaling pathways. Additionally, considering the negative regulatory role of Pim-2 in T cells, further in-depth studies on their respective functions are needed.</p>","PeriodicalId":13550,"journal":{"name":"Inflammation Research","volume":null,"pages":null},"PeriodicalIF":4.8,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11457682/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141855363","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
RIP3 regulates doxorubicin-induced intestinal mucositis via FUT2-mediated α-1,2-fucosylation. RIP3通过FUT2介导的α-1,2-岩藻糖基化调节多柔比星诱导的肠粘膜炎。
IF 4.8 3区 医学 Q2 CELL BIOLOGY Pub Date : 2024-10-01 Epub Date: 2024-08-24 DOI: 10.1007/s00011-024-01932-2
Wei Wen, Xiaomin Hu, Jialin Liu, Fanxin Zeng, Yihua Xu, Ye Yuan, Chunyan Gao, Xueting Sun, Bo Cheng, Jue Wang, Xinli Hu, Rui-Ping Xiao, Xing Chen, Xiuqin Zhang

Objective: Intestinal mucositis is one of the common side effects of anti-cancer chemotherapy. However, the molecular mechanisms involved in mucositis development remain incompletely understood. In this study, we investigated the function of receptor-interacting protein kinase 3 (RIP3/RIPK3) in regulating doxorubicin-induced intestinal mucositis and its potential mechanisms.

Methods: Intestinal mucositis animal models were induced in mice for in vivo studies. Rat intestinal cell line IEC-6 was used for in vitro studies. RNA‑seq was used to explore the transcriptomic changes in doxorubicin-induced intestinal mucositis. Intact glycopeptide characterization using mass spectrometry was applied to identify α-1,2-fucosylated proteins associated with mucositis.

Results: Doxorubicin treatment increased RIP3 expression in the intestine and caused severe intestinal mucositis in the mice, depletion of RIP3 abolished doxorubicin-induced intestinal mucositis. RIP3-mediated doxorubicin-induced mucositis did not depend on mixed lineage kinase domain-like (MLKL) but on α-1,2-fucosyltransferase 2 (FUT2)-catalyzed α-1,2-fucosylation on inflammation-related proteins. Deficiency of MLKL did not affect intestinal mucositis, whereas inhibition of α-1,2-fucosylation by 2-deoxy-D-galactose (2dGal) profoundly attenuated doxorubicin-induced inflammation and mucositis.

Conclusions: RIP3-FUT2 pathway is a central node in doxorubicin-induced intestinal mucositis. Targeting intestinal RIP3 and/or FUT2-mediated α-1,2-fucosylation may provide potential targets for preventing chemotherapy-induced intestinal mucositis.

目的:肠粘膜炎是抗癌化疗的常见副作用之一:肠粘膜炎是抗癌化疗的常见副作用之一。然而,有关粘膜炎发生的分子机制仍不完全清楚。本研究探讨了受体相互作用蛋白激酶3(RIP3/RIPK3)在调控多柔比星诱导的肠粘膜炎中的功能及其潜在机制:方法:在小鼠体内诱导肠粘膜炎动物模型,进行体内研究。大鼠肠细胞株 IEC-6 用于体外研究。采用 RNA-seq 技术探讨多柔比星诱导的肠粘膜炎的转录组变化。利用质谱分析法鉴定与粘膜炎相关的α-1,2-岩藻糖基化蛋白:结果:多柔比星治疗增加了肠道中 RIP3 的表达,并导致小鼠出现严重的肠粘膜炎。RIP3介导的多柔比星诱导的粘膜炎并不依赖于混合系激酶结构域样(MLKL),而是依赖于α-1,2-岩藻糖基转移酶2(FUT2)催化的炎症相关蛋白上的α-1,2-岩藻糖基化。缺乏MLKL不会影响肠粘膜炎,而用2-脱氧-D-半乳糖(2dGal)抑制α-1,2-岩藻糖基化可显著减轻多柔比星诱导的炎症和粘膜炎:结论:RIP3-FUT2通路是多柔比星诱发肠粘膜炎的中心节点。针对肠道RIP3和/或FUT2介导的α-1,2-岩藻糖基化可能为预防化疗诱发的肠粘膜炎提供潜在靶点。
{"title":"RIP3 regulates doxorubicin-induced intestinal mucositis via FUT2-mediated α-1,2-fucosylation.","authors":"Wei Wen, Xiaomin Hu, Jialin Liu, Fanxin Zeng, Yihua Xu, Ye Yuan, Chunyan Gao, Xueting Sun, Bo Cheng, Jue Wang, Xinli Hu, Rui-Ping Xiao, Xing Chen, Xiuqin Zhang","doi":"10.1007/s00011-024-01932-2","DOIUrl":"10.1007/s00011-024-01932-2","url":null,"abstract":"<p><strong>Objective: </strong>Intestinal mucositis is one of the common side effects of anti-cancer chemotherapy. However, the molecular mechanisms involved in mucositis development remain incompletely understood. In this study, we investigated the function of receptor-interacting protein kinase 3 (RIP3/RIPK3) in regulating doxorubicin-induced intestinal mucositis and its potential mechanisms.</p><p><strong>Methods: </strong>Intestinal mucositis animal models were induced in mice for in vivo studies. Rat intestinal cell line IEC-6 was used for in vitro studies. RNA‑seq was used to explore the transcriptomic changes in doxorubicin-induced intestinal mucositis. Intact glycopeptide characterization using mass spectrometry was applied to identify α-1,2-fucosylated proteins associated with mucositis.</p><p><strong>Results: </strong>Doxorubicin treatment increased RIP3 expression in the intestine and caused severe intestinal mucositis in the mice, depletion of RIP3 abolished doxorubicin-induced intestinal mucositis. RIP3-mediated doxorubicin-induced mucositis did not depend on mixed lineage kinase domain-like (MLKL) but on α-1,2-fucosyltransferase 2 (FUT2)-catalyzed α-1,2-fucosylation on inflammation-related proteins. Deficiency of MLKL did not affect intestinal mucositis, whereas inhibition of α-1,2-fucosylation by 2-deoxy-D-galactose (2dGal) profoundly attenuated doxorubicin-induced inflammation and mucositis.</p><p><strong>Conclusions: </strong>RIP3-FUT2 pathway is a central node in doxorubicin-induced intestinal mucositis. Targeting intestinal RIP3 and/or FUT2-mediated α-1,2-fucosylation may provide potential targets for preventing chemotherapy-induced intestinal mucositis.</p>","PeriodicalId":13550,"journal":{"name":"Inflammation Research","volume":null,"pages":null},"PeriodicalIF":4.8,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142046590","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Minocycline alleviates microglia ferroptosis by inhibiting HO-1 during cerebral ischemia-reperfusion injury. 米诺环素通过抑制脑缺血再灌注损伤过程中的HO-1减轻小胶质细胞的铁卟啉沉积。
IF 4.8 3区 医学 Q2 CELL BIOLOGY Pub Date : 2024-10-01 Epub Date: 2024-08-07 DOI: 10.1007/s00011-024-01927-z
Lin Wang, Yao Wang, Mengyue Wu, Xing Jin, Yifei Chen, Zhenhuan Guo, Xiaowen Meng, Jianyou Zhang, Fuhai Ji

Objective: Ischemic stroke is a leading cause of death and disability in individuals worldwide. Cerebral ischemia-reperfusion injury (CIRI) typically results in severe secondary injury and complications following reperfusion therapy. Microglia play critical roles in the inflammatory reaction of CIRI. However, less attention has been given to microglial death in this process. Our study aims to explore microglial death in CIRI and the effects and mechanism of minocycline treatment on microglia.

Methods: A middle cerebral artery occlusion (MCAO) model was applied to induce CIRI in rats. At 0 h, 24 h and 48 h post-operation, rats were intraperitoneally injected with 45 mg/kg minocycline. Neurological deficit scoring, 2,3,5-triphenyltetrazolium chloride (TTC) staining, assessment of activated microglia and examination of mitochondrial structure were conducted and checked at 72 h after reperfusion. Additionally, an in vitro model of oxygen-glucose deprivation/reperfusion (OGD/R) model was established. BV-2 cells were treated with various pharmacological inhibitors of cell death or minocycline. Cell viability, lipid peroxidation, mitochondrial structure and function, and labile Fe2+ and ferroptosis-associated gene/protein levels were measured. Hemin was used for further validation after transcriptome analysis.

Results: In the MCAO and OGD/R models, ferroptosis was identified as a major form of microglial death. Minocycline inhibited microglia ferroptosis by reducing HO-1 expression. In addition, minocycline improved mitochondrial membrane potential, mitochondrial structures and microglial survival in vivo. Minocycline also decreased labile Fe2+ levels, lipid peroxidation, and expression of ferritin heavy chain (FTH) and it improved mitochondrial structure and function in vitro. Upregulation of HO-1 counteracted the protective effect of minocycline.

Conclusion: Ferroptosis is a major form of microglial death in CIRI. The protective mechanism of minocycline in CIRI partially hinges on its ability to effectively ameliorate microglia ferroptosis by downregulating HO-1 expression. Consequently, targeting microglia ferroptosis is a promising treatment for CIRI.

目的:缺血性中风是导致全球死亡和残疾的主要原因。脑缺血再灌注损伤(CIRI)通常会导致严重的继发性损伤和再灌注治疗后的并发症。小胶质细胞在 CIRI 的炎症反应中发挥着关键作用。然而,人们对这一过程中的小胶质细胞死亡关注较少。我们的研究旨在探讨 CIRI 中的小胶质细胞死亡以及米诺环素治疗对小胶质细胞的影响和机制:方法:应用大脑中动脉闭塞(MCAO)模型诱导大鼠 CIRI。方法:应用大脑中动脉闭塞(MCAO)模型诱导大鼠CIRI,分别于术后0 h、24 h和48 h腹腔注射45 mg/kg米诺环素。在再灌注后 72 小时进行神经功能缺损评分、2,3,5-三苯基氯化四氮唑(TTC)染色、活化小胶质细胞评估和线粒体结构检查。此外,还建立了氧-葡萄糖剥夺/再灌注(OGD/R)体外模型。BV-2 细胞接受各种细胞死亡药理抑制剂或米诺环素处理。对细胞活力、脂质过氧化、线粒体结构和功能、可溶性 Fe2+ 和铁突变相关基因/蛋白水平进行了测定。转录组分析后,血红蛋白被用于进一步验证:结果:在MCAO和OGD/R模型中,铁突变被确定为小胶质细胞死亡的主要形式。米诺环素通过减少 HO-1 的表达抑制了小胶质细胞的铁凋亡。此外,米诺环素还能改善线粒体膜电位、线粒体结构和体内小胶质细胞的存活率。米诺环素还能降低可变铁2+水平、脂质过氧化和铁蛋白重链(FTH)的表达,并能改善体外线粒体的结构和功能。HO-1的上调抵消了米诺环素的保护作用:结论:铁突变是 CIRI 中小胶质细胞死亡的主要形式。米诺环素在 CIRI 中的保护机制部分取决于其通过下调 HO-1 表达有效改善小胶质细胞铁凋亡的能力。因此,针对小胶质细胞铁突变是一种治疗 CIRI 的有前途的方法。
{"title":"Minocycline alleviates microglia ferroptosis by inhibiting HO-1 during cerebral ischemia-reperfusion injury.","authors":"Lin Wang, Yao Wang, Mengyue Wu, Xing Jin, Yifei Chen, Zhenhuan Guo, Xiaowen Meng, Jianyou Zhang, Fuhai Ji","doi":"10.1007/s00011-024-01927-z","DOIUrl":"10.1007/s00011-024-01927-z","url":null,"abstract":"<p><strong>Objective: </strong>Ischemic stroke is a leading cause of death and disability in individuals worldwide. Cerebral ischemia-reperfusion injury (CIRI) typically results in severe secondary injury and complications following reperfusion therapy. Microglia play critical roles in the inflammatory reaction of CIRI. However, less attention has been given to microglial death in this process. Our study aims to explore microglial death in CIRI and the effects and mechanism of minocycline treatment on microglia.</p><p><strong>Methods: </strong>A middle cerebral artery occlusion (MCAO) model was applied to induce CIRI in rats. At 0 h, 24 h and 48 h post-operation, rats were intraperitoneally injected with 45 mg/kg minocycline. Neurological deficit scoring, 2,3,5-triphenyltetrazolium chloride (TTC) staining, assessment of activated microglia and examination of mitochondrial structure were conducted and checked at 72 h after reperfusion. Additionally, an in vitro model of oxygen-glucose deprivation/reperfusion (OGD/R) model was established. BV-2 cells were treated with various pharmacological inhibitors of cell death or minocycline. Cell viability, lipid peroxidation, mitochondrial structure and function, and labile Fe<sup>2+</sup> and ferroptosis-associated gene/protein levels were measured. Hemin was used for further validation after transcriptome analysis.</p><p><strong>Results: </strong>In the MCAO and OGD/R models, ferroptosis was identified as a major form of microglial death. Minocycline inhibited microglia ferroptosis by reducing HO-1 expression. In addition, minocycline improved mitochondrial membrane potential, mitochondrial structures and microglial survival in vivo. Minocycline also decreased labile Fe<sup>2+</sup> levels, lipid peroxidation, and expression of ferritin heavy chain (FTH) and it improved mitochondrial structure and function in vitro. Upregulation of HO-1 counteracted the protective effect of minocycline.</p><p><strong>Conclusion: </strong>Ferroptosis is a major form of microglial death in CIRI. The protective mechanism of minocycline in CIRI partially hinges on its ability to effectively ameliorate microglia ferroptosis by downregulating HO-1 expression. Consequently, targeting microglia ferroptosis is a promising treatment for CIRI.</p>","PeriodicalId":13550,"journal":{"name":"Inflammation Research","volume":null,"pages":null},"PeriodicalIF":4.8,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11445363/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141901537","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ferroptosis: a potential target for acute lung injury. 铁蛋白沉积:急性肺损伤的潜在靶点
IF 4.8 3区 医学 Q2 CELL BIOLOGY Pub Date : 2024-10-01 Epub Date: 2024-08-17 DOI: 10.1007/s00011-024-01919-z
Yuqi Wen, Yang Liu, Weihong Liu, Wenli Liu, Jinyan Dong, Qingkuo Liu, Zhen Yu, Hongsheng Ren, Hao Hao

Acute lung injury (ALI) is caused by a variety of intrapulmonary and extrapulmonary factors and is associated with high morbidity and mortality. Oxidative stress is an important part of the pathological mechanism of ALI. Ferroptosis is a mode of programmed cell death distinguished from others and characterized by iron-dependent lipid peroxidation. This article reviews the metabolic regulation of ferroptosis, its role in the pathogenesis of ALI, and the use of ferroptosis as a therapeutic target regarding the pharmacological treatment of ALI.

急性肺损伤(ALI)由多种肺内和肺外因素引起,发病率和死亡率都很高。氧化应激是急性肺损伤病理机制的重要组成部分。铁氧化是一种有别于其他细胞死亡的程序性细胞死亡模式,其特点是铁依赖性脂质过氧化。本文综述了铁变态反应的代谢调控、铁变态反应在 ALI 发病机制中的作用,以及将铁变态反应作为 ALI 药物治疗的靶点。
{"title":"Ferroptosis: a potential target for acute lung injury.","authors":"Yuqi Wen, Yang Liu, Weihong Liu, Wenli Liu, Jinyan Dong, Qingkuo Liu, Zhen Yu, Hongsheng Ren, Hao Hao","doi":"10.1007/s00011-024-01919-z","DOIUrl":"10.1007/s00011-024-01919-z","url":null,"abstract":"<p><p>Acute lung injury (ALI) is caused by a variety of intrapulmonary and extrapulmonary factors and is associated with high morbidity and mortality. Oxidative stress is an important part of the pathological mechanism of ALI. Ferroptosis is a mode of programmed cell death distinguished from others and characterized by iron-dependent lipid peroxidation. This article reviews the metabolic regulation of ferroptosis, its role in the pathogenesis of ALI, and the use of ferroptosis as a therapeutic target regarding the pharmacological treatment of ALI.</p>","PeriodicalId":13550,"journal":{"name":"Inflammation Research","volume":null,"pages":null},"PeriodicalIF":4.8,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141995666","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pharmacological targeting of adaptor proteins in chronic inflammation. 慢性炎症中适应蛋白的药理靶标。
IF 4.8 3区 医学 Q2 CELL BIOLOGY Pub Date : 2024-10-01 Epub Date: 2024-07-25 DOI: 10.1007/s00011-024-01921-5
Shubhi Raizada, Alexander G Obukhov, Shreya Bharti, Khandu Wadhonkar, Mirza S Baig

Background: Inflammation, a biological response of the immune system, can be triggered by various factors such as pathogens, damaged cells, and toxic compounds. These factors can lead to chronic inflammatory responses, potentially causing tissue damage or disease. Both infectious and non-infectious agents, as well as cell damage, activate inflammatory cells and trigger common inflammatory signalling pathways, including NF-κB, MAPK, and JAK-STAT pathways. These pathways are activated through adaptor proteins, which possess distinct protein binding domains that connect corresponding interacting molecules to facilitate downstream signalling. Adaptor molecules have gained widespread attention in recent years due to their key role in chronic inflammatory diseases.

Methods: In this review, we explore potential pharmacological agents that can be used to target adaptor molecules in chronic inflammatory responses. A comprehensive analysis of published studies was performed to obtain information on pharmacological agents.

Conclusion: This review highlights the therapeutic strategies involving small molecule inhibitors, antisense oligonucleotide therapy, and traditional medicinal compounds that have been found to inhibit the inflammatory response and pro-inflammatory cytokine production. These strategies primarily block the protein-protein interactions in the inflammatory signaling cascade. Nevertheless, extensive preclinical studies and risk assessment methodologies are necessary to ensure their safety.

背景:炎症是免疫系统的一种生物反应,可由病原体、受损细胞和有毒化合物等各种因素引发。这些因素会导致慢性炎症反应,可能造成组织损伤或疾病。感染性和非感染性病原体以及细胞损伤都会激活炎症细胞并触发常见的炎症信号通路,包括 NF-κB、MAPK 和 JAK-STAT 通路。这些途径是通过适配蛋白激活的,适配蛋白具有不同的蛋白结合域,可连接相应的相互作用分子,促进下游信号传导。近年来,适配体分子因其在慢性炎症性疾病中的关键作用而受到广泛关注:在这篇综述中,我们探讨了在慢性炎症反应中可用于靶向适配体分子的潜在药理制剂。我们对已发表的研究进行了全面分析,以获取有关药理制剂的信息:本综述重点介绍了涉及小分子抑制剂、反义寡核苷酸疗法和传统药用化合物的治疗策略,这些策略已被发现可抑制炎症反应和促炎症细胞因子的产生。这些策略主要是阻断炎症信号级联中蛋白质与蛋白质之间的相互作用。然而,为了确保其安全性,有必要进行广泛的临床前研究和风险评估方法。
{"title":"Pharmacological targeting of adaptor proteins in chronic inflammation.","authors":"Shubhi Raizada, Alexander G Obukhov, Shreya Bharti, Khandu Wadhonkar, Mirza S Baig","doi":"10.1007/s00011-024-01921-5","DOIUrl":"10.1007/s00011-024-01921-5","url":null,"abstract":"<p><strong>Background: </strong>Inflammation, a biological response of the immune system, can be triggered by various factors such as pathogens, damaged cells, and toxic compounds. These factors can lead to chronic inflammatory responses, potentially causing tissue damage or disease. Both infectious and non-infectious agents, as well as cell damage, activate inflammatory cells and trigger common inflammatory signalling pathways, including NF-κB, MAPK, and JAK-STAT pathways. These pathways are activated through adaptor proteins, which possess distinct protein binding domains that connect corresponding interacting molecules to facilitate downstream signalling. Adaptor molecules have gained widespread attention in recent years due to their key role in chronic inflammatory diseases.</p><p><strong>Methods: </strong>In this review, we explore potential pharmacological agents that can be used to target adaptor molecules in chronic inflammatory responses. A comprehensive analysis of published studies was performed to obtain information on pharmacological agents.</p><p><strong>Conclusion: </strong>This review highlights the therapeutic strategies involving small molecule inhibitors, antisense oligonucleotide therapy, and traditional medicinal compounds that have been found to inhibit the inflammatory response and pro-inflammatory cytokine production. These strategies primarily block the protein-protein interactions in the inflammatory signaling cascade. Nevertheless, extensive preclinical studies and risk assessment methodologies are necessary to ensure their safety.</p>","PeriodicalId":13550,"journal":{"name":"Inflammation Research","volume":null,"pages":null},"PeriodicalIF":4.8,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141758492","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Inflammation Research
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1